✦ LIBER ✦

Efficacy and Safety of Imatinib Mesylate for Patients in the First Chronic Phase of Chronic Myeloid Leukemia: Results of a Japanese Phase II Clinical Study

✍ Scribed by Yasuo Morishima; Michinori Ogura; Miki Nishimura; Fumiharu Yazaki; Masami Bessho; Hideaki Mizoguchi; Shigeru Chiba; Hisamaru Hirai; Tetsuzo Tauchi; Akio Urabe; Masatomo Takahashi; Kazunori Ohnishi; Toshiya Yokozawa; Nobuhiko Emi; Masami Hirano; Chihiro Shimazaki; Shinji Nakao; Yasukazu Kawai; Masahiro Fujimoto; Hirokuni Taguchi; Itsuro Jinnai; Ryuzo Ohno

Book ID: 111835361
Publisher: Carden Jennings Publishing
Year: 2004
Tongue: English
Weight: 93 KB
Volume: 80
Category: Article
ISSN: 0925-5710
DOI: 10.1532/ijh97.04074

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Population pharmacokinetics of imatinib

Population pharmacokinetics of imatinib mesylate in patients with chronic-phase chronic myeloid leukaemia: results of a phase III study

✍ H. Schmidli; B. Peng; G-J. Riviere; R. Capdeville; M. Hensley; I. Gathmann; A. E 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 225 KB

Efficacy of imatinib dose escalation in

Efficacy of imatinib dose escalation in patients with chronic myeloid leukemia in chronic phase

✍ Hagop M. Kantarjian; Richard A. Larson; Francois Guilhot; Stephen G. O'Brien; Ma 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 230 KB 👁 3 views

Long-term safety and efficacy of imatini

Long-term safety and efficacy of imatinib mesylate (Gleevec®) in elderly patients with chronic phase chronic myelogenous leukemia: Results of the AFR04 study

✍ Philippe Rousselot; Pascale Cony-Makhoul; Franck Nicolini; François Xavier Mahon 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 177 KB

Imatinib for newly diagnosed chronic-pha

Imatinib for newly diagnosed chronic-phase chronic myeloid leukemia: results of a prospective study in Japan

✍ Tadashi Nagai; Jin Takeuchi; Nobuaki Dobashi; Yuzuru Kanakura; Shuichi Taniguchi 📂 Article 📅 2010 🏛 Carden Jennings Publishing 🌐 English ⚖ 284 KB

Nilotinib in imatinib-resistant or imati

Nilotinib in imatinib-resistant or imatinib-intolerant patients with chronic myeloid leukemia in chronic phase: 48-month follow-up results of a phase II study

✍ Giles, F J; le Coutre, P D; Pinilla-Ibarz, J; Larson, R A; Gattermann, N; Ottman 📂 Article 📅 2012 🏛 Nature Publishing Group 🌐 English ⚖ 383 KB

Erratum: Efficacy of imatinib dose escal

Erratum: Efficacy of imatinib dose escalation in patients with chronic myeloid leukemia in chronic phase

✍ Hagop M. Kantarjian; Richard A. Larson; Francois Guilhot; Stephen G. O'Brien; Ma 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB 👁 2 views